How much funding has Morphic Therapeutic raised?

Morphic Therapeutic has raised $414.0M in total funding, most recently a Series C round.

Who are Morphic Therapeutic's investors?

Morphic Therapeutic's investors include SR One, Pfizer Ventures, Omega Funds.

When was Morphic Therapeutic founded?

Morphic Therapeutic was founded in 2015.

Where is Morphic Therapeutic headquartered?

Morphic Therapeutic is headquartered in Waltham, Massachusetts, United States.

What industry is Morphic Therapeutic in?

Morphic Therapeutic operates in Biotech, Healthcare.

How many employees does Morphic Therapeutic have?

Morphic Therapeutic has 51-200 employees.

Morphic Therapeutic

Waltham, United States · Founded 2015 · $414.0M raised

Biotech

Healthcare

Headquarters: Waltham, Massachusetts
Employees: 51–200
Founded: 2015
Business Model: B2B

Total Funding: $414.0M
Last Round: $276.0M Series CMay 2023
Rounds: 4

About

Morphic Therapeutic was a Waltham, Massachusetts-based biopharmaceutical company founded in 2014 by Timothy A. Springer of Harvard Medical School, focused on developing a new generation of small-molecule oral integrin therapies for immunological, fibrotic, neoplastic, and vascular diseases. The company built its platform on decades of integrin biology research and partnered with major pharmaceutical companies including AbbVie and Schrödinger. In July 2024, Eli Lilly acquired Morphic Therapeutic to expand its immunology pipeline with oral integrin therapies.

Summary

Morphic Therapeutic is a Biotech company based in Waltham, United States, founded in 2015. It has raised $414.0M in total across 4 rounds, most recently a $276.0M Series C round in May 2023. Investors include SR One, Pfizer Ventures and Omega Funds.